Status | Study |
Recruiting |
Study Name: Fludarabine Based RIC for Bone Marrow Failure Syndromes Condition: Bone Marrow Failure Syndromes Date: 2016-10-07 Interventions: Other: MRD-BMT with Fludarabine-based RIC for Acquired AA |
Not yet recruiting |
Study Name: Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) Condition: Severe Aplastic Anemia Date: 2016-09-27 Interventions: Drug: Antithymocyte Globulin A |
Recruiting |
Study Name: Clinical Phase II Trial to Evaluate CD34+ Cells Mobilization and Collection in Patients With Fanconi Anemia for Subsequent Transduction With a Lentiviral Vector Carring FANCA Gene. FANCOSTEM-1 Condition: Fanconi Anemia Date: 2016-09-06 Interventions: Drug: filgrastim G-CSF (12 |
Not yet recruiting |
Study Name: King's Invasive Aspergillosis Study II Condition: Aplastic Anemia Leukemia, Myeloid, Acute Date: 2016-08-18 Interventions: Drug: Posaconazole |
Not yet recruiting |
Study Name: Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia Condition: Anemia, Aplastic Date: 2016-07-26 Interventions: Drug: rhTPO rhTPO |
Recruiting |
Study Name: NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia Condition: Severe Aplastic Anemia Aplastic Anemia Date: 2016-07-12 Interventions: Drug: Thymoglobulin Day -9: 0. |
Not yet recruiting |
Study Name: ATG Combined With Cyclophosphamide And Cord Blood Transfusion in Treating Patients With Severe Aplastic Anemia Condition: Aplastic Anemia Date: 2016-07-06 Interventions: Drug: Rabbit ATG, (Genzyme) AT |
Recruiting |
Study Name: Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia Condition: Severe Aplastic Anemia Date: 2016-07-06 Interventions: Drug: Fludarabine 30 mg/m2 IV |
Not yet recruiting |
Study Name: Study of MRI Monitoring in Patients With Aplastic Anemia and Low or Int-1 Risk of MDS Complicated With Iron Overload Condition: Aplastic Anemia Dysmyelopoietic Syndromes Date: 2016-07-05 |
Active, not recruiting |
Study Name: Study of Romiplostim(AMG531) in Subjects With Aplastic Anemia Condition: Aplastic Anemia Date: 2016-05-09 Interventions: Biological: Romiplostim Weekly SC administration |